Joshua S. Prince Vista Gen Therapeutics, Inc. (VTGN) insider trading activity

VTGN Quotes by TradingView

Joshua S. Prince is Chief Operating Officer of VistaGen Therapeutics, Inc.. Currently has a direct ownership of 15,249 shares of VTGN, which is worth approximately $58,251. The most recent transaction as insider was on Dec 31, 2025, when has been sold 4,386 shares (Common Stock) at a price of $0.56 per share, resulting in proceeds of $2,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.2K
40.38% 3M change
154.96% 12M change
Total Value Held $58,251

Joshua S. Prince Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Grant, award, or other acquisition
$2,456 $0.56 p/Share
4,386 Added 22.34%
15,249 Common Stock
Jun 30 2025
BUY
Grant, award, or other acquisition
$8,299 $1.7 p/Share
4,882 Added 31.01%
10,863 Common Stock
Dec 31 2024
BUY
Grant, award, or other acquisition
$8,308 $2.51 p/Share
3,310 Added 35.63%
5,981 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
$7,906 $2.96 p/Share
2,671 Added 50.0%
2,671 Common Stock
JSP

Joshua S. Prince

Chief Operating Officer
South San Francisco, CA

Track Institutional and Insider Activities on VTGN

Follow VistaGen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTGN shares.

Notify only if

Insider Trading

Get notified when an Vista Gen Therapeutics, Inc. insider buys or sells VTGN shares.

Notify only if

News

Receive news related to VistaGen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VTGN